| Pubmed ID |
Author | Year | Title |
26910747 |
Gursoy AY | 2016 | Is cystatin C level altered in women with polycystic ovary syndrome? |
26911305 |
Yilmaz N | 2016 | Follicular fluid total antioxidant capacity levels in PCOS. |
26913233 |
Mokhtar S | 2015 | ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial. |
26913880 |
Sabbadin C | 2016 | The story of spironolactones from 1957 to now: from sodium balance to inflammation. |
26913980 |
Calan M | 2016 | A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome. |
26914110 |
Russo V | 2016 | Electrocardiographic indexes of arrhythmic risk in polycystic ovary syndrome. |
26914398 |
Qi X | 2016 | The role of anti-M?llerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome. |
26915924 |
Elizondo-Montemayor L | 2017 | Gynecologic and Obstetric Consequences of Obesity in Adolescent Girls. |
26919524 |
Rahaman SN | 2016 | Cloning, expression, purification, crystallization and X-ray crystallographic analysis of recombinant human C1ORF123 protein. |
26921577 |
Iwasa T | 2015 | The advancement of the onset of vaginal opening in female rats subjected to chronic testosterone treatment occurs independently of hypothalamic Kiss1 and RFRP expression. |
26921624 |
Kim JY | 2016 | Distinguishing characteristics of metabolically healthy versus metabolically unhealthy obese adolescent girls with polycystic ovary syndrome. |
26922384 |
Nahuis MJ | 2016 | Does the postcoital test predict pregnancy in WHO II anovulatory women? A prospective cohort study. |
26924153 |
Moran LJ | 2016 | Erratum to: Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome. |
26924636 |
Kollmann M | 2016 | Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis. |
26927948 |
Paul C | 2016 | Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. |
26932210 |
Wang S | 2016 | [Effects of compound malt pills on expressions of ER? and ER? in ovaries of rats with letrozole-induced polycystic ovarian syndrome]. |
26935780 |
Ding Y | 2016 | Point mutation in mitochondrial tRNA gene is associated with polycystic ovary syndrome and insulin resistance. |
26938199 |
Tian Y | 2016 | Variants in FSHB Are Associated With Polycystic Ovary Syndrome and Luteinizing Hormone Level in Han Chinese Women. |
26941198 |
Guoqing Z | 2016 | Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome. |
26941806 |
Amjadi F | 2015 | Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: A case-control study. |
26943610 |
Nandi A | 2016 | Is there a role for vitamin D in human reproduction? |
26944460 |
Worsley R | 2016 | Hormones and Female Sexual Dysfunction: Beyond Estrogens and Androgens--Findings from the Fourth International Consultation on Sexual Medicine. |
26945402 |
Wang Y | 2016 | Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial. |
26948535 |
Goulis DG | 2016 | Presence of type 1 diabetes in women with polycystic ovary syndrome: Does it have any impact on anti-M?llerian hormone concentrations? |
26951881 |
Nehir Aytan A | 2016 | Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. |
26952035 |
Gaspar RS | 2016 | Reproductive alterations in hyperinsulinemic but normoandrogenic MSG obese female rats. |
26952754 |
Cadagan D | 2016 | Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome. |
26952756 |
Pandey V | 2016 | Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat. |
26952782 |
Marsh CA | 2016 | Working memory in women with polycystic ovary syndrome. |
26953707 |
Ciresi A | 2016 | Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency. |
26955991 |
Laz?rov? I | 2015 | [Diagnostics of polycystic ovary syndrome]. |
26956932 |
de Graaff EC | 2017 | Risk factors for stillbirth in a socio-economically disadvantaged urban Australian population. |
26960762 |
Thomson RL | 2016 | Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial. |
26961579 |
?ebkowska A | 2016 | Serum anti-M?llerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. |
26964728 |
Pasquali R | 2016 | Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. |
26965431 |
Hvidman HW | 2016 | Infertile women below the age of 40 have similar anti-M?llerian hormone levels and antral follicle count compared with women of the same age with no history of infertility. |
26967765 |
Gul OO | 2015 | Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome. |
26968296 |
Kalra S | 2016 | Endocrine and metabolic effects of Glucagon like peptide 1 receptor agonists (GLP1RA). |
26968928 |
Ramezanali F | 2016 | Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-M?llerian hormone. |
26969461 |
Kume T | 2016 | A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome. |
26972165 |
De Sousa SM Dr | 2016 | Metabolic syndrome, diet and exercise. |
26975253 |
Kokosar M | 2016 | Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome. |
26976018 |
Krawiec P | 2016 | Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl. |
26977831 |
Braun MM | 2016 | Diagnosis and Management of Endometrial Cancer. |
26979020 |
Nicolino M | 2015 | [WHAT IS THE RISK FOR CHILDHOOD OBESITY?]. |
26979943 |
Szczuko M | 2016 | Effect of IGF-I and TNF-? on intensification of steroid pathways in women with PCOS phenotypes are not identical. Enhancement of progesterone pathway in women with PCOS increases the concentration of TNF-?. |
26980102 |
Salehabadi M | 2016 | Association of G22A and A4223C ADA1 gene polymorphisms and ADA activity with PCOS. |
26980590 |
?ak?ro?lu Y | 2016 | The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. |
26983014 |
Carlus SJ | 2016 | Is MTHFR 677 C>T Polymorphism Clinically Important in Polycystic Ovarian Syndrome (PCOS)? A Case-Control Study, Meta-Analysis and Trial Sequential Analysis. |
26983336 |
Gundelach T | 2016 | [Metformin for the treatment of polycystic ovary syndrome]. |
26984837 |
Wu Y | 2016 | Acupuncture for treating polycystic ovary syndrome: guidance for future randomized controlled trials. |
26985336 |
Zahiri Z | 2016 | Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran. |
26985764 |
Oru? AS | 2016 | A Study of Serum Soluble CD 163 Levels in Women with Polycystic Ovary Syndrome. |
26989412 |
Kyaw Tun T | 2016 | Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome. |
26990942 |
Torchen LC | 2016 | Evidence for Increased 5?-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome. |
26993517 |
Mikaeili S | 2016 | Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome. |
26995146 |
Nambiar V | 2016 | Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome. |
26995881 |
Sirota I | 2016 | Insulin Resistance and ?-cell Function Calculated by Homeostasis Model Assessment in Lean, Overweight, and Obese Women with Polycystic Ovary Syndrome. |
26995885 |
Polat SB | 2016 | Thyroid Disorders in Young Females with Polycystic Ovary Syndrome and Correlation of Thyroid Volume with Certain Hormonal Parameters. |
26995937 |
Brazert M | 2015 | Insulin-like growth factor-1 isoforms in human ovary. Preliminary report on the expression of the IGF-1 gene in PCOS patients and healthy controls. |
26997468 |
Cappy H | 2016 | Low vitamin D3 and high anti-M?llerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link? |
26997601 |
Shahrami SH | 2016 | The Relation between Diverse Phenotypes of PCOS with Clinical Manifestations, Anthropometric Indices and Metabolic Characteristics. |
26997714 |
Bubna AK | 2016 | Metformin - For the dermatologist. |
26999875 |
Klein J | 2015 | Polycystic Ovarian Syndrome. |
27000076 |
Verrotti A | 2016 | Valproic Acid Metabolism and its Consequences on Sexual Functions. |
27001999 |
Huang X | 2016 | Identification of altered microRNAs and mRNAs in the cumulus cells of PCOS patients: miRNA-509-3p promotes oestradiol secretion by targeting MAP3K8. |
27002301 |
Conti R | 2016 | Polycystic ovary syndrome and vitiligo: simple association or tight connection? |
27003383 |
Emekci Ozay O | 2016 | Role of kisspeptin in polycystic ovary syndrome (PCOS). |
27007571 |
Victor VM | 2016 | Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase. |
27008892 |
Mumm H | 2016 | Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome. |
27011370 |
Wang B | 2016 | Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome. |
27014589 |
Agarwal S | 2016 | Liver X Receptor-? polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo. |
27018331 |
Wang CC | 2016 | The clinical and biochemical characteristics associated with insulin resistance in non-obese young women<sup/>. |
27018756 |
Fruzzetti F | 2016 | Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin. |
27018935 |
Fields EL | 2016 | Treatment Considerations for the Cardiometabolic Signs of Polycystic Ovary Syndrome: A Review of the Literature Since the 2013 Endocrine Society Clinical Practice Guidelines. |
27025792 |
Forouhi N | 2016 | Serum C1q and tumor necrosis factor (TNF)-related protein 9 in women with Polycystic Ovary Syndrome. |
27026772 |
Suvarna Y | 2016 | Comparison of efficacy of metformin and oral contraceptive combination of ethinyl estradiol and drospirenone in polycystic ovary syndrome. |
27028341 |
Gupta A | 2016 | Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome. |
27032432 |
Tolstrup J | 2016 | [Complications in pregnant women with polycystic ovary syndrome]. |
27034186 |
Glintborg D | 2016 | Endocrine and metabolic characteristics in polycystic ovary syndrome. |
27034774 |
Ouyang P | 2016 | Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists. |
27035648 |
Liu HY | 2016 | Transcription factor?microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome. |
27039650 |
Davies N | 2016 | PCOS: Polycystic Ovarian Syndrome. |
27039809 |
Yousuf SD | 2016 | The ICAM-1 Gly241Arg Polymorphism is Not Associated With Polycystic Ovary Syndrome - Results from a Case Control study in Kashmir, India. |
27042970 |
Torchen LC | 2016 | Increased antim?llerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. |
27046189 |
Li L | 2016 | The Role of Heat Shock Protein 90B1 in Patients with Polycystic Ovary Syndrome. |
27046958 |
Allahbadia GN | 2016 | Primum Non Nocere. |
27047563 |
Riahinejad S | 2015 | Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome. |
27049276 |
Yang B | 2016 | Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome. |
27050252 |
Razavi M | 2016 | The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. |
27052492 |
Behboudi-Gandevani S | 2016 | Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. |
27052493 |
Hrovat A | 2016 | SORCS1 polymorphism and insulin secretion in obese women with polycystic ovary syndrome. |
27053365 |
Lu C | 2016 | Developmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep. |
27056885 |
Xu J | 2016 | Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell. |
27060006 |
Zhao S | 2016 | Metabolic actions of insulin in ovarian granulosa cells were unaffected by hyperandrogenism. |
27060174 |
Toftager M | 2016 | Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. |
27061312 |
Luotola K | 2016 | IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome. |
27061597 |
Turkmen S | 2016 | The author's reply: Blood allopregnanolone levels in women with polycystic ovary syndrome. |
27061682 |
Kanamarlapudi V | 2016 | Luteinizing hormone/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active. |
27061737 |
Saito K | 2016 | Blood allopregnanolone levels in women with polycystic ovary syndrome. |
Showing 13,401–13,500 of 14,368